Arcturus Therapeutics Ltd. Stock Split Ratio
Arcturus Therapeutics Ltd. reported Stock Split Ratio of 14.29% for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Notes › Equity
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2019-05-13
- Arcturus Therapeutics Ltd. stockholders' equity note, stock split, conversion ratio for the quarter ending 2019-03-31 was 14.29%.
- Arcturus Therapeutics Ltd. stockholders' equity note, stock split, conversion ratio for fiscal 2018 was 14.29%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|---|---|---|
| 2019-03-31 | 14.29% 10-Q · filed 2019-05-13 | |||||
| 2018-12-31 | 14.29% 10-K · filed 2019-03-18 | |||||
| 2018-09-30 | 14.29% 6-K · filed 2018-11-07 | |||||
| 2018-06-30 | 14.29% 6-K · filed 2018-09-28 | |||||
| 2017-11-15 | 14.29% 20-F · filed 2018-05-14 | 14.29% 10-K · filed 2019-03-18 |